Laurie R Braun

Laurie R Braun

UNVERIFIED PROFILE

Are you Laurie R Braun?   Register this Author

Register author
Laurie R Braun

Laurie R Braun

Publications by authors named "Laurie R Braun"

Are you Laurie R Braun?   Register this Author

4Publications

57Reads

17Profile Views

Effects of Pitavastatin on Insulin Sensitivity and Liver Fat: A Randomized Clinical Trial.

J Clin Endocrinol Metab 2018 11;103(11):4176-4186

Program in Nutritional Metabolism and Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/advance-article/doi/10.1210/jc
Publisher Site
http://dx.doi.org/10.1210/jc.2018-01446DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194811PMC
November 2018

Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation.

Growth Horm IGF Res 2017 12 7;37:1-6. Epub 2017 Oct 7.

Program in Nutritional Metabolism and Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Department of Pediatrics, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ghir.2017.10.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705434PMC
December 2017

Disorders of Growth and Stature.

Pediatr Rev 2017 Jul;38(7):293-304

Pediatric Endocrine Unit and.

View Article

Download full-text PDF

Source
http://pedsinreview.aappublications.org/lookup/doi/10.1542/p
Publisher Site
http://dx.doi.org/10.1542/pir.2016-0178DOI Listing
July 2017

Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial.

J Clin Endocrinol Metab 2016 Mar 21;101(3):1123-33. Epub 2015 Dec 21.

Program in Nutritional Metabolism and Neuroendocrine Unit (H.M., T.L.S., C.S., S.S., L.R.B., S.E.L., M.N.F., S.K.G.), Massachusetts General Hospital, Boston, Massachusetts 02114; Harvard Medical School (H.M., T.L.S., A.L.D.S.-C., L.R.B., S.E.L., M.T., H.L., M.-E.P., S.K.G.), Boston, Massachusetts 02115; Pediatric Endocrine Unit (T.L.S., L.R.B.), Massachusetts General Hospital, Boston, Massachusetts 02114; Research Division (A.L.D.S.-C., M.-E.P.), Joslin Diabetes Center, Boston, Massachusetts 02215; Department of Physical Medicine and Rehabilitation (W.R.F.), Vanderbilt University Medical Center, Nashville, Tennessee 37212; Department of Physical Medicine and Rehabilitation (W.R.F.), Harvard Medical School/Spaulding Rehabilitation Hospital, Boston, Massachusetts 02114; Department of Physiology (W.R.F.), University of Puerto Rico School of Medicine, San Juan, Puerto Rico 00936; Department of Radiology (M.T.), Massachusetts General Hospital, Boston, Massachusetts 02114; and MGH Biostatistics Center (H.L.), Massachusetts General Hospital and Harvard Medical Center, Boston, Massachusetts 02114.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2015-3696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803166PMC
March 2016